Antioxidants for CNS ischaemia and trauma

Bibliography

• MURRAY CJ, LOPEZ AD: Mortality by cause for eight regions of the world: Global Burden of Disease Study. Lancet(1997) 349:1269–1276.
   PubMed Web of Science ®Google Scholar
• THE NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE RT-PA STROKE STUDY GROUP: Tissue plasminogen activator for acute ischemic stroke. N Engl. 1. Med.(1995) 333:1581–1587.
   Google Scholar
• DIRNAGL U, IADECOLA C, MOSKOWITZ MA: Pathobiology of ischaemic stroke: an integrated view. Trends. Neurosci(1999) 22:391–397.
   PubMed Web of Science ®Google Scholar
• ••Excellent review on pathophysiology ofcerebral ischaemia.
   Google Scholar
• SIESJO BK, AGARDH CD, BENGTSSON F: Free radicals and brain damage. Cerebrovasc. Brain Metab. Rev(1989) 1:165–211.
   PubMedGoogle Scholar
• ••Reviews all aspects of free radical mediateddamage.
   Google Scholar
• LEWEN A, MATZ E CHAN PH: Free radical pathways in CNS injury. 1. Neurotrauma(2000) 17:871–890.
   PubMed Web of Science ®Google Scholar
• ••Reviews all aspects of free radical mediateddamage especially in CNS trauma.
   Google Scholar
• PETERS 0, BACK T, LINDAUER U et al.:Increased formation of reactive oxygen species after permanent and reversible middle cerebral artery occlusion in the rat. Cereb. Blood Flow Metab.(1998) 18:196–205.
   Google Scholar
• •Important publication analysing radical production in cerebral ischaemia in rats.
   Google Scholar
• PELLEGRINI-GIAMPIETRO DE: Free radicals and the pathogenesis of neuronal death: cooperative role of excitatory amino acids. Adv. Exp. Med. Biol.(1994) 366:59–71.
   PubMedGoogle Scholar
• BOVERIS A, CHANCE B: The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. 1(1973) 134:707–716.
   Google Scholar
• KINUTA Y, KIMURA M, ITOKAWA Y, ISHIKAWA M, KIKUCHI H: Changes in xanthine oxidase in ischemic rat brain. 1. Neurosurg.(1989) 71:417–420.
   PubMed Web of Science ®Google Scholar
• ATLANTE A, GAGLIARDI S, MINERVINI GM, CIOTTI MT, MARRA E, CALISSANO P: Glutamate neurotoxicity in rat cerebellar granule cells: a major role for xanthine oxidase in oxygen radical formation. 1. Neurochem.(1997) 68:2038–2045.
   PubMed Web of Science ®Google Scholar
• KELLOGG EW, FRIDOVICH I: Superoxide, hydrogen peroxide and singlet oxygen in lipid peroxidation by a xanthine oxidase system. I Biol. Chem.(1975) 250:8812–8817.
   Google Scholar
• KUEHL FAJ, EGAN RW: Prostaglandins, arachidonic acid and inflammation. Science(1980) 210:978–984.
   PubMedGoogle Scholar
• CHAN PH, KAWASE M, MURAKAMI K et al.:Overexpression of SOD1 in transgenic rats protects vulnerable neurons against ischemic damage after global cerebral ischemia and reperfusion. Neurosci(1998) 18:8292–8299.
   Google Scholar
• KONDO T, REAUME AG, HUANG TT et al.:Reduction of CuZn-superoxide dismutase activity exacerbates neuronal cell injury and edema formation after transient focal cerebral ischemia. j Neurosci(1997) 17:4180–4189.
   PubMed Web of Science ®Google Scholar
• MIKAWA S, KINOUCHI H, KAMII H et al.:Attenuation of acute and chronic damage following traumatic brain injury in copper, zinc-superoxide dismutase transgenic mice. I Neurosurg.(1996) 85:885–891.
   PubMed Web of Science ®Google Scholar
• BOLAN- OS JP, ALMEIDA A, STEWART V et al.:Nitric oxide-mediated damage in the brain: mechanisms and implications for neurodegenerative diseases. 1. Neurochem.(1997) 68:2227–2240.
   Google Scholar
• KELLER JN, KINDY MS, HOLTSBERG FW etal.:Mitochondrial manganese superoxide dismutase prevents neural apoptosis and reduces ischemic brain injury: suppression of peroxynitrite production, lipid peroxidation and mitochondrial dysfunction. 1. Neurosci18:687–697.
   Google Scholar
• HALLIWELL B: Reactive oxygen species and the central nervous system. I Neurochem.(1992) 59:1609–1623.
   PubMed Web of Science ®Google Scholar
• ••Excellent review on the generation andimportance of ROS in the CNS.
   Google Scholar
• FAROOQUI AA, HORROCKS LA: Lipid peroxides in the free radical pathophysiology of brain diseases. Cell. Mol. Neurobiol.(1998) 18:599–608.
   PubMed Web of Science ®Google Scholar
• KNOWLES RG, MONCADA S: Nitric oxide synthases in mammals. Biochem.(1994) 298:249–258.
   Web of Science ®Google Scholar
• MONCADA S, PALMER RIVI, HIGGS EA: Nitric oxide: physiology, pathophysiology and pharmacology. Pharmacol. Rev(1991) 43:109–142.
   PubMed Web of Science ®Google Scholar
• ••Comprehensive information on all aspectof nitric oxide.
   Google Scholar
• MORI T, ASANO T, MATSUI T et al.:Intraluminal increase of superoxide anion following transient focal cerebral ischemia in rats. Brain Res.(1999) 816:350–357.
   PubMed Web of Science ®Google Scholar
• KUMAR M, LIU GJ, FLOYD RA, GRAMMAS P: Anoxic injury of endothelial cells increases production of nitric oxide and hydroxyl radicals. Biochem. Biophys. Res. Commun.(1996) 219:497–501.
   PubMedGoogle Scholar
• GARDNER AM, XU FH, FADY C etal.: Apoptosis vs.nonapoptotic cytotoxicity induced by hydrogen peroxide. Free Rad. Biol. Med.(1997) 22: 73–83.
   Google Scholar
• BONFOCO E, KRAINC D, ANKARCRONA M, NICOTERA P, LIPTON S: Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-D-aspartate or nitric oxide/superoxide in cortical cell cultures. Proc. Nati Acad. Li.(1995) 92:7162–7166.
   PubMed Web of Science ®Google Scholar
• LOVE S: Oxidative stress in brain ischemia. Brain Pathol.(1999) 9:119–131.
   PubMed Web of Science ®Google Scholar
• ATLANTE A, CALISSANO P, BOBBA A, AZZARITI A, MARRA E, PASSARELLA S: Cytochrome c is released from mitochondria in a reactive oxygen species (ROS)-dependent fashion and can operate as a ROS scavenger and as a respiratory substrate in cerebellar neurons undergoing excitotoxic death. 1. Biol. Chem.(2000) 275: 37159–37166.
   PubMed Web of Science ®Google Scholar
• FUJIMURA M, MORITA-FUJIMURA Y, NOSHITA N, SUGAWARA T, KAWASE M, CHAN PH: The cytosolic antioxidant copper/zinc-superoxide dismutase prevents the early release of mitochondrial cytochrome c in ischemic brain after transient focal cerebral ischemia in mice. 1. Neurosci.(2000) 20: 2817–2824.
   PubMed Web of Science ®Google Scholar
• TRAYSTMAN RJ, KIRSCH JR, KOEHLER RC: Oxygen radical mechanisms of brain injury following ischemia and reperfusion. I Appl. Physiol.(1991) 71:1185–1195.
   PubMed Web of Science ®Google Scholar
• IADECOLA C, ZHANG F, CASEY R, NAGAYAMA M, ROSS ME: Delayed reduction of ischemic brain injury and neurological deficits in mice lacking the inducible nitric oxide synthase gene. I Neurosci.(1997) 17:9157–9164.
   Google Scholar
• HUANG Z, HUANG PL, PANAHIAN N, DALKARA T, FISHMAN MC, MOSKOWITZ MA: Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase. Science(1994) 265:1883–1885.
   PubMed Web of Science ®Google Scholar
• WADA K, CHATZIPANTELI K, BUSTO R, DIETRICH WD: Effects of L-NAME and 7-NI on NOS catalytic activity and behavioral outcome after traumatic brain injury in the rat. I Neurotrauma(1999) 16:203–212.
   PubMedGoogle Scholar
• IADECOLA C, ZHANG F, XU X: Inhibition of inducible nitric oxide synthase ameliorates cerebral ischemic damage. Am. PhysiaL(1995) 268:R286–R292.
   Google Scholar
• NANRI K, MONTECOT C, SPRINGHETTI V, SEYLAZ J, PINARD E: The selective inhibitor of neuronal nitric oxide synthase, 7-nitroindazole, reduces the delayed neuronal damage due to forebrain ischemia in rats. Stroke(1998) 29:1248–1253.
   PubMed Web of Science ®Google Scholar
• STOFFEL M, RINECKER M, PLESNILA N, ERISKAT J, BAETHMANN A: Role of nitric oxide in the secondary expansion of a cortical brain lesion from cold injury. j. Neuratrauma(2001): In press.
   Google Scholar
• XIONG Y, PETERSON PL, MUIZELAAR JP, LEE CP: Amelioration of mitochondrial function by a novel antioxidant U-101033E following traumatic brain injury in rats. j. Neuratrauma(1997) 14:907–917.
   PubMed Web of Science ®Google Scholar
• HALL ED, ANDRUS PK, SMITH SL et al.:Pyrrolopyrimidines: novel brain-penetrating antioxidants with neuroprotective activity in brain injury and ischemia models. j. PharmacaL Esp. Ther.(1997) 281:895–904.
   PubMed Web of Science ®Google Scholar
• •Protective effects of pyrrolopyrimidines assessed in various models of CNS damage.
   Google Scholar
• LEWEN A, HILLERED L: Involvement of reactive oxygen species in membrane phospholipid breakdown and energy perturbation after traumatic brain injury in the rat. j. Neuratrauma(1998) 15:521–530.
   PubMed Web of Science ®Google Scholar
• HALL ED, MCCALL JM, MEANS ED: Therapeutic potential of the lazaroids (21-aminosteroids) in acute central nervous system trauma, ischemia and subarachnoid hemorrhage. Adv. Pharmacol.(1994) 28:221–268.
   PubMedGoogle Scholar
• FAROOQUE M, OLSSON Y, HILLERED L: Pretreatment with alpha-phenyl-N-tert- butyl-nitrone (PBN) improves energy metabolism after spinal cord injury in rats. Neuratrauma(1997) 14:469–476.
   PubMedGoogle Scholar
• FAROOQUE M, OLSSON Y, HOLTZ A: Effect of the 21-aminosteroid U74006F and methylprednisolone on motor function recovery and oedema after spinal cord compression in rats. Acta Neural. Scant/.(1994) 89:36–41.
   PubMedGoogle Scholar
• DAWSON DA, MASAYASU H, GRAHAM DI, MACRAE IM: The neuroprotective efficacy of ebselen (a glutathione peroxidase mimic) on brain damage induced by transient focal cerebral ischaemia in the rat. Neurosci. Lett.(1995) 185:65–69.
   PubMed Web of Science ®Google Scholar
• CLEMENS JA, SAUNDERS RD, HO PE PHEBUS LA, PANETTA JA: The antioxidant LY231617 reduces global ischemic neuronal injury in rats. Stroke(1993) 24:716–722.
   PubMed Web of Science ®Google Scholar
• HALL ED: Effects of the 21-aminosteroid U74006F on posttraumatic spinal cord ischemia in cats. I Neurosurg.(1988) 68:462–465.
   PubMed Web of Science ®Google Scholar
• ROOF RL, HALL ED: Gender differences in acute CNS trauma and stroke: neuroprotective effects of estrogen and progesterone. j. Neuratrauma(2000) 17:367–388.
   PubMed Web of Science ®Google Scholar
• ••Summary of the current knowledge onoestrogens and progesterones in CNS ischaemia or trauma.
   Google Scholar
• CULMSEE C, VEDDER H, RAVATI A et al.:Neuroprotection by estrogens in a mouse model of focal cerebral ischemia and in cultured neurons: evidence for a receptor-independent antioxidative mechanism. j. Cereb. Blood Flow Metab.(1999) 19:1263–1269.
   PubMed Web of Science ®Google Scholar
• MOOSMANN B, BEHL C: The antioxidant neuroprotective effects of estrogens and phenolic compounds are independent from their estrogenic properties. Proc. Natl. Acad. Sci. USA(1999) 96:8867–8872.
   PubMed Web of Science ®Google Scholar
• SCHMID-ELSAESSER R, HUNGERHUBER E, ZAUSINGER S, BAETHMANN A, REULEN HJ: Neuroprotective effects of the novel brain-penetrating antioxidant U-101033E and the spin-trapping agent alpha-phenyl-N-tert-butyl nitrone (PEN). Exp. Brain Res.(2000) 130:60–66.
   PubMedGoogle Scholar
• YANG Y, LI Q, SHUAIB A: Neuroprotection by 2-h postischemia administration of two free radical scavengers, alpha-phenyl-n-tert-butyl-nitrone (PEN) and N-tert-butyl-(2-sulfopheny1)-nitrone (S-PBN), in rats subjected to focal embolic cerebral ischemia. Exp. Neural.(2000) 163:39–45.
   PubMedGoogle Scholar
• CARNEY JM, FLOYD RA: Protection against oxidative damage to CNS by alpha-phenyl-tert-butyl nitrone (PEN) and other spin-trapping agents: a novel series of nonlipid free radical scavengers. I Mai Neurosci.(1991) 3:47–57.
   PubMed Web of Science ®Google Scholar
• TYURIN VA, TYURINA YY, BORISENKO GG et al.:Oxidative stress following traumatic brain injury in rats: quantitation of biomarkers and detection of free radical intermediates. j. Neurochem.(2000) 75:2178–2189.
   PubMed Web of Science ®Google Scholar
• HENSLEY K, CARNEY JM, STEWART CA, TABATABAIE T, PYE Q, FLOYD RA: Nitrone-based free radical traps as neuroprotective agents in cerebral ischaemia and other pathologies. Int. Rev. NeurobiaL(1997) 40:299–317.
   PubMed Web of Science ®Google Scholar
• SZABO C, FERRER-SUETA G, ZINGARELLI B, SOUTHAN GJ, SALZMAN AL, RADI R: Mercaptoethylguanidine and guanidine inhibitors of nitric-oxide synthase react with peroxynitrite and protect against peroxynitrite-induced oxidative damage. Biol. Chem.(1997) 272:9030–9036.
   Google Scholar
• LYSKO PG, LYSKO KA, YUE TL, WEBB CL, GU JL, FEUERSTEIN G: Neuroprotective effects of carvedilol, a new antihypertensive agent, in cultured rat cerebellar neurons and in gerbil global brain ischemia. Stroke(1992) 23:1630–1635.
   PubMed Web of Science ®Google Scholar
• STANDEFER M, LITTLE JR: Improved neurological outcome in experimental focal cerebral ischemia treated with propranolol. Neurosurgery(1986) 18:136–140.
   PubMedGoogle Scholar
• SALVEMINI D, WANG ZQ, ZWEIER JL et al.:A nonpeptidyl mimic of superoxide dismutase with therapeutic activity in rats. Science(1999) 286:304–306.
   PubMed Web of Science ®Google Scholar
• LIAO Z, LIU W, LIU J, JIANG Y, SHI J, LIU C: A study on superoxide dismutase activity of some model compounds. I Inorg. Biochem.(1994) 55:165–174.
   PubMed Web of Science ®Google Scholar
• DAY BJ, FRIDOVICH I, CRAPO JD: Manganic porphyrins possess catalase activity and protect endothelial cells against hydrogen peroxide-mediated injury. Arch. Biochem. Biophys.(1997) 347:256–262.
   PubMed Web of Science ®Google Scholar
• REN GEL D, DIEZ-NAVAJAS A, SERNA-RICO A, VEIGA P, MUGA A, MILICUA JC: Exogenously incorporated ketocarotenoids in large unilamellar vesicles. Protective activity against peroxidation. Biochim. Biophys. Acta(2000) 1463:179–187.
   PubMedGoogle Scholar
• DOREY G, LOCKHART B, LESTAGE P, CASARA P: New quinolinic derivatives as centrally active antioxidants. Bioarg. Med. Chem. Lett.(2000) 10:935–939.
   PubMed Web of Science ®Google Scholar
• NASIR Al, GUNDERSEN LL, RISE F et al.:Inhibition of lipid peroxidation mediated by indolizines. Bioarg. Med. Chem. Lett.(1998) 8:1829–1832.
   PubMed Web of Science ®Google Scholar
• DOMANY G, BARTA-SZALAI G, GERE A, FARSANG G, SCHON I: 441-Naphthylamino)-piperidines as inhibitors of lipid peroxidation. Arzneimittelforschung(1996) 46:553–556.
   PubMed Web of Science ®Google Scholar
• CALLAWAY JK, KNIGHT MJ, WATKINS DJ, BEART PM, JARROTT B: Delayed treatment with AM-36, a novel neuroprotective agent, reduces neuronal damage after endothelin- I-induced middle cerebral artery occlusion in conscious rats. Stroke(1999) 30:2704–2712.
   PubMed Web of Science ®Google Scholar
• FIANDER H, SCHNEIDER H: Compounds that induce isoforms of glutathione S-transferase with properties of a critical enzyme in defense against oxidative stress. Biochem. Biophys. Res. Commun.(1999) 262:591–595.
   PubMed Web of Science ®Google Scholar
• POEGGELER B, PAPPOLLA MA, HARDELAND R etal.:Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res.(1999) 815:382–388.
   Google Scholar
• SMITH RA, PORTEOUS CM, COULTER CV, MURPHY MP: Selective targeting of an antioxidant to mitochondria. Eur. Biochem.(1999) 263:709–716.
   PubMedGoogle Scholar
• LARGERON M, LOCKHART B, PFEIFFER B, FLEURY MB: Synthesis and in vitroevaluation of new 8-amino-1,4-benzoxazine derivatives as neuroprotective antioxidants. j. Med. Chem.(1999) 42:5043–5052.
   PubMed Web of Science ®Google Scholar
• BOGOUSSLAVSKY J, DEKEYSER J, DIENER HC et al.:Neuroprotection as initial therapy in acute stroke - Third report of an Ad Hoc Consensus Group Meeting. Cerebrovasc. Dis.(1998) 8:59–72.
   PubMed Web of Science ®Google Scholar
• •Discussing the importance of combination therapy.
   Google Scholar
• KOROSHETZ WJ, MOSKOWITZ MA: Emerging treatments for stroke in humans. Trends. Pharmacol. Li.(1996) 17:227–233.
   PubMed Web of Science ®Google Scholar
• SCHMID-ELSAESSER R, HUNGERHUBER E, ZAUSINGER S, BAETHMANN A, REULEN HJ: Neuroprotective efficacy of combination therapy with two different antioxidants in rats subjected to transient focal ischemia. Brain Res.(1999) 816:471–479.
   PubMed Web of Science ®Google Scholar
• SPINNEWYN B, CORNET S, AUGUET M, CHABRIER PE: Synergistic protective effects of antioxidant and nitric oxide synthase inhibitor in transient focal ischemia. j Cereb. Blood Flow Metab.(1999) 19:139–143.
   PubMed Web of Science ®Google Scholar
• SCHMID-ELSAESSER R, ZAUSINGER S, HUNGERHUBER E, PLESNILA N, BAETHMANN A, REULEN HJ: Superior neuroprotective efficacy of a novel antioxidant (U-101033E) with improved blood-brain barrier permeability in focal cerebral ischemia. Stroke(1997) 28: 2018-2024.
   Google Scholar
• SCHMID-ELSAESSER R, ZAUSINGER S, HUNGERHUBER E, BAETHMANN A, REULEN HJ: Neuroprotective effects of combination therapy with tirilazad and magnesium in rats subjected to reversible focal cerebral ischemia. Neurosurgery(1999) 44:163–171.
   PubMed Web of Science ®Google Scholar
• SCHMID-ELSAESSER R, HUNGERHUBER E, ZAUSINGER S, BAETHMANN A, REULEN HJ: Combination drug therapy and mild hypothermia: a promising treatment stratergy for reversible focal cerebral ischemia. Stroke(1999) 30:1891-1899. Patents
   Google Scholar